Janus kinase 2 (JAK2) mutation was discovered in 2005 in Ph chromosome negative myeloproliferative disorders and was found in the whole of PV cases and about 50% of the ET and PMF cases (4, 5). This evidence concerns the gene JAK2 and myeloproliferative disorder.